跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Relsis
Approved
STANDARD
Relsis
Alkem Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
45f5ee1a5db068df
Company
Alkem Laboratories Limited
Type
Standard
Approval Details
Approval Id
45f5ee1a5db068df
Drug Approval Philippines Name
Relsis
Product Name
Relsis
Registration Number
DR-XY48032
Brand Name
Relsis
Generic Name
Fingolimod (As Hydrochloride)
Dosage Form
Capsule
Dosage Strength
500 mcg
Manufacturer
Alkem Laboratories Limited
Importer
Alkem Laboratories Corporation
Distributor
Alkem Laboratories Corporation
Issuance Date
24 May 2022
Expiry Date
24 May 2027
Pharmacologic Category
Immunosuppressant
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
45f5ee1a5db068df
Type
Standard
Back to Philippines FDA Approvals